Status:
RECRUITING
Incidence of 107 Lymph Node Metastasis
Lead Sponsor:
Fudan University
Conditions:
Esophageal Cancer
Eligibility:
All Genders
20-85 years
Brief Summary
the study was to document the incidence o subcarinal lymph node metastasis, and the risk factors of metastasis.
Detailed Description
Esophageal cancer remains one of the most prevalent malignancies worldwide, with surgery serving as the cornerstone for resectable cases. Although patient survival has improved with the integration of...
Eligibility Criteria
Inclusion
- patients with esophageal squamous cell carcinoma
- clinical staging: cT1-4a N0/+ M0.
- no history of other malignancy.
Exclusion
- esophageal cancer in the neck
- poor physical status to have esophagectomy.
Key Trial Info
Start Date :
July 21 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 21 2030
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT07165184
Start Date
July 21 2025
End Date
July 21 2030
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032